Bid for review of health provider framework
The relationship a health care provider and the government department that sets its annual mandate should be reviewed, the minister responsible for it has said.
Health and Social Care Minister Clare Christian will ask members to approve the setting up of a committee to review the at the April sitting of Tynwald.
Manx Care was created as an arm's-length body in 2021 following a review by former NHS Foundation Trust chief executive Sir Jonathan Michael.
Christian will ask for the review to focus on the governance framework, the division of responsibilities, and the statutory relationship between the two bodies.
It comes as the same time as a shake-up at the Department of Health and Social Care (DHSC), which has seen two ministers step away as political representatives, with three new members appointed to the team.
Home Affairs Minister Jane Poole-Wilson and Cabinet Office Minister David Ashford were appointed to the DHSC on an interim basis since November 2024 after the resignation of former minister Lawrie Hooper.
The new appointees, Minister without portfolio Tim Crookall, Stu Peters MHK and Diane Kelsey MLC, now join Peter Reid MLC who was appointed to the department in March.
While Manx Care delivers the day-to-day running of health services, the department sets the policy and strategy, and creates a mandate for Manx Care to monitor its performance.
In January, the provider confirmed it was facing a projected £15m overspend for the 2024/2025 financial year and announced a raft of cost-cutting measures in a bid to to stay within its £346m budget.
Christian, who took on the post as minister in November, said as it was four years since Manx Care had become operational the time was right to "take stock and review the working arrangements".
She said: "I want to ensure that the island's health and care system, that we all value so highly, makes the best use of its resources and has clear lines of accountability."
The minister said she believed the proposal would "enable us to see what lessons we have learned" and "consider whether we need to make any improvements or changes that will ensure we can provide the best service to the public over the coming years".
Welcoming the move, chairman of the Manx Care board Wendy Reid said: "The review, due to be considered by the board, recognises that current legislation and oversight arrangements provide significant challenges regarding the independence, accountability and decision making for Manx Care."
If backed by Tynwald, the committee would be tasked with bringing the terms of reference for the review to the June sitting of the parliament for approval, with a final report due in December.
A general debate on the most recent Manx Care mandate and operating plan was rejected Tynwald last month.
Former minister Lawrie Hooper will ask members to support changes to the current mandate at the April sitting.
Read more stories from the Isle of Man on the BBC, watch BBC North West Tonight on BBC iPlayer and follow BBC Isle of Man on Facebook and X.
Politicians delay debate on health care mandate
Three new MLCs take on government department roles
Three new ministers announced in cabinet shake-up
Manx Care takes over running health services
Manx Care
Tynwald - Parliament of the Isle of Man
Isle of Man Government - Department of Health and Social Care
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Liberty HealthShare Earns Charity Navigator Four-Star Rating
CANTON, Ohio, June 11, 2025 /PRNewswire/ -- Liberty HealthShare®, the nation's most-comprehensive healthcare sharing ministry, has earned a "Four-Star" rating by Charity Navigator, ranking it among the country's best non-profit organizations. This rating designates Liberty HealthShare, which is celebrating its 30th anniversary in 2025, as an official "Give with Confidence" charity, indicating that it is using its donations effectively based on Charity Navigator's criteria. Charity Navigator, the nation's largest and most influential non-profit evaluator, reviews more than 200,000 organizations on their accountability and finance, impact and results, culture and community, and leadership and adaptability. Liberty HealthShare's 90% score is its highest rating ever and is up from the previous 88% score. "We are delighted to provide Liberty HealthShare with third-party accreditation that validates their operational excellence," said Michael Thatcher, president and chief executive officer of Charity Navigator. "The Four-Star Rating is the highest possible rating an organization can achieve. We are eager to see the good work that Liberty HealthShare can accomplish in the years ahead." "Our Four-Star Charity Navigator rating is further validation that our members can trust our commitment to good governance and financial transparency, and also that we're using our donor's gifts effectively," said Dorsey Morrow, Liberty HealthShare chief executive officer. "We hope it will introduce our ministry to new supporters who can help us advance our vision to build a healthcare sharing community that exemplifies Jesus Christ and empowers like-minded people to manage their healthcare journey," he added. Liberty HealthShare has also earned a "GuideStar Gold Seal" from Candid, ranking it among the country's best non-profits for transparency and accountability. Established in 1995, Liberty HealthShare provides a cost-effective, faith-based alternative to health insurance. Members enjoy the freedom to choose their own providers while participating in a compassionate, Christian community. Transparency and stewardship are central, with programs tailored for families, seniors, and individuals. Liberty HealthShare offers six affordable medical cost sharing programs that are designed to fit the needs and budgets of individuals as well as different types and sizes of families. Suggested monthly share amounts for individuals range from $87-$369. Share amounts for families of four start at $319 per month. Most programs include access to both urgent care and mental wellness telehealth visits along with access to discounts for prescription drugs, dental care, vision care, and even LASIK surgery. Liberty Dental, the ministry's dental sharing program, features suggested monthly share amounts as low as $35 and allows members to see the dentist of their choice without any network restrictions. As Liberty HealthShare is not insurance, enrollment is available year-round with no requirement for special life events to qualify. For more information about its sharing programs visit or call (855) 585-4237. Earlier this year, Liberty HealthShare established the Sharing Hearts Fund for Pediatric Wellness, a charitable arm of the ministry that seeks to provide support to Stark County, Ohio families with medical needs related to pediatric wellness. Liberty HealthShare is a non-profit 501(c) (3) charitable Christian medical cost-sharing ministry focused on members helping each other in times of need. The faith-based program, which facilitates healthsharing for its members, is a caring community of health-conscious individuals and families who choose to support one another and agree to the Christian values of stewardship to make healthcare affordable for all. Liberty HealthShare is not an insurance company nor is it offered through an insurance company. Liberty HealthShare's Sharing Programs do not guarantee or promise that a member's medical bills will be paid or assigned to others for payment. Whether anyone chooses to pay a member's medical bills will be totally voluntary. As such, Liberty HealthShare's Sharing Programs should never be considered as a substitute for an insurance policy. Whether a member receives any payments for medical expenses and whether or not Liberty HealthShare continues to operate, the member is always liable for any unpaid bills. View original content to download multimedia: SOURCE Liberty HealthShare Sign in to access your portfolio
Yahoo
a day ago
- Yahoo
TN trans care ban: AG said defending case to SCOTUS, expected to rule soon, was God's will
DALLAS — Potentially days before the U.S. Supreme Court rules in a landmark case on a ban on transgender youth receiving certain medical care, Tennessee's attorney general told a room of Southern Baptists he believes it was God's providence that he argued before the land's highest court. "I'm in the middle of things that are so much bigger than I have any business being in the middle of. But I'm there for a reason," Tennessee Attorney General Jonathan Skrmetti said during a June 10 panel discussion at the Kay Bailey Hutchison Convention Center in Dallas. 'So, I just try to remember it's not about me and that God puts his people where he needs them, where he wants them." Skrmetti's office is defending Tennessee's ban on gender transition treatments for transgender minors, which a Nashville family with a transgender teenager is challenging. The Supreme Court may decide on the case as early as June 12, and a majority of justices have signaled a friendly disposition toward upholding Tennessee's law that took effect in June 2023. The June 10 event was organized by the Nashville-based SBC's public policy arm, the Ethics & Religious Liberty Commission. Skrmetti and another panelist, Alliance Defending Freedom senior vice president Ryan Bangert, said the case is about science and the degree to which courts can decide public policy. But Skrmetti and Bangert, whose law firm is helping represent Tennessee in U.S. v. Skrmetti, acknowledged faith is another key component of this story and will potentially be a resounding victory for conservative Christians. More: Meet the Tennessee family behind the US Supreme Court's major transgender health care case 'I would be ready to have good conversations with your congregants, good conversations with your fellow church members about what this case means not just from a legal perspective. But from a broader cultural perspective,' Bangert said at the June 10 panel. 'I would be ready to have that conversation: 'God willing, the law has been upheld. What do we do know?'' Alliance Defending Freedom has been a decisive force in several recent U.S. Supreme Court cases that have reversed precedent in favor of conservative Christian ideals. Examples include Dobbs v. Jackson Women's Health Organization that overturned Roe v. Wade, Kennedy v. Bremerton dealing with public prayer on a high school sports field, and 303 Creative v. Elenis about a Christian web designer's refusal to work with same-sex couples. The Southern Baptist Convention is the nation's largest Protestant denomination. The Ethics & Religious Liberty Commission stated its opposition to transition treatment for transgender people in resolutions at past SBC annual meetings and has been a vocal proponent of bans in Tennessee and other states. Bangert said at the June 10 panel there are 26 states with bans like Tennessee's and the decision in U.S. v. Skrmetti could affect those other laws. The ERLC filed an amicus brief in U.S. v. Skrmetti, for which the SBC-affiliated agency hired a Southern Baptist lawyer to carefully and forcefully assert the Southern Baptists' position on the issue. Skrmetti praised the ERLC's amicus brief during the June 10 panel, saying it provided a theological rationale for Tennessee's law. Skrmetti's office cannot make that theological argument in its defense before the Supreme Court because an establishment clause requires the state to approach the case from a religiously neutral perspective. Skrmetti, who attends a Church of Christ congregation in Nashville, said at the June 10 panel in his capacity at Tennessee's attorney general that his religion is not a factor in how he approaches the case. But personally, he told the crowd of Southern Baptists in Dallas that the outcome will be meaningful as a person of faith. 'Pray for my team that all of us that if we win, win gracefully in a way that reinforces both shining God's light into the world,' Skrmetti said. Liam Adams covers religion for The Tennessean, part of the USA TODAY Network. Reach him at ladams@ or on social media @liamsadams. This article originally appeared on Nashville Tennessean: Skrmetti cites God's will to his role in SCOTUS trans care case at SBC
Yahoo
a day ago
- Yahoo
Groundbreaking cancer treatment which ‘destroys tumours with sound' to be rolled out on NHS
NHS patients will be the first in Europe to benefit from a pioneering new cancer treatment which uses ultrasound to destroy tumours. The technology, known as histotripsy, offers a non-invasive treatment capable of breaking down liver cancer tissue without surgery, radiation or chemotherapy, with minimal damage to the surrounding organs, according to the Department for Health and Social Care (DHSC). First approved by US regulators in October 2023, histotripsy uses pulsed sound waves to create 'bubble clouds' from gases present in the targeted tissue and tumour. When these bubbles pop, within microseconds, a shockwave is released which is capable of breaking up a mass and killing cancerous cells, while avoiding the harms of radiation and reducing the risks of bleeding, infection, and damage to surrounding non-targeted tissue. Treatment is delivered via a single session – potentially taking just 30 minutes – with limited or no pain, a quick recovery, and can be performed as a day case, according to the DHSC. The first NHS patients are set to be treated this summer at Addenbrooke's Hospital in Cambridge, where the technology – which uses a device called an Edison System, created by US firm HistoSonics – is being debuted after a donation from the Li Ka Shing Foundation. Cancer Research UK describes liver cancer as the 17th most common cancer in the UK and the 8th most frequent cause of cancer death. More than 8,000 people received a new diagnoses in 2022, with liver cancer incidence across the UK having surged by 42 per cent over the past decade, according to the British Liver Trust. So far, more than 1,500 patients worldwide have received treatment using histotripsy, mainly in the United States – following approval by the US Food and Drug Administration in late 2023. According to 12-month follow-up data from HistoSonics' previous clinical trials, which involved patients for whom other treatments had been either unsuccessful or unavailable, overall survival rates after one year were 73.3 per cent for primary liver cancer, and 48.6 per cent for those with secondary tumours. The paper, published in the Annals of Surgery journal in April, noted that both tumour control and survival rates were similar to those among other current treatments. The UK's new device is expected to be fully installed in Cambridge later this year, where it will be used initially to treat patients with primary and secondary liver tumours. Wider research on how this could potentially treat tumours in other organs – such as the pancreas and kidneys – is underway. The technology has been approved in the UK via the innovative devices access pathway, which aims to enable faster approvals of medical devices and treatments which evidence shows are safe, efficient and can fill unmet need. 'This is a strong example of smart, agile regulation in action,' said James Pound, of the Medicines and Healthcare products Regulatory Agency (MHRA). 'It's a major step forward for patients with liver cancer and shows how the UK can be a frontrunner in supporting responsible innovation that meets real clinical need.' While 'regulation is vital to protect patients', the government is 'slashing red tape, so game-changing new treatments reach the NHS front line quicker – transforming healthcare', said health secretary Wes Streeting. Hailing histotripsy as 'an exciting new technology that will make a huge difference to patients', Roland Sinker, chief executive of Cambridge University Hospitals, said: 'By offering this non-invasive, more targeted treatment we can care for more people as outpatients and free up time for surgeons to treat more complex cases. 'The faster recovery times mean patients will be able to return to their normal lives more quickly, which will also reduce pressure on hospital beds, helping us ensure that patients are able to receive the right treatment at the right time.' Fiona Carey, a kidney cancer patient who co-chairs Cambridge's patient advisory group, added: 'This is seriously good news. A new, non-invasive option to treat these cancers is very welcome indeed. 'For patients for whom ordinary surgery is no longer an option, this could make all the difference.'
